Brief: FDA Approves Daiichi Sankyo's fam-trastuzumab deruxtecan-nxki For Two Breast Cancer Indications
15/05/2026 23:19
May 15 (Reuters) - FDA: FDA: APPROVES TWO SEPARATE INDICATIONS FOR FAM-TRASTUZUMAB DERUXTECAN-NXKI IN HER2-POSITIVE EARLY-STAGE BREAST CANCER FDA: APPROVES TWO COMPANION DIAGNOSTIC DEVICES FOR HER2-POSITIVE PATIENT IDENTIFICATION WITH T-DXD - WEBSITE ((Reuters.Briefs@thomsonreuters.com;))